BM
Last reporting period 30 Jun, 2024
Updated —
Last price
—
Market cap $B
100.34
Exchange
XSWX - Six Swiss Exchange
6.7 B
Last period Cash and equivalents ,USD
-77%
Cash and equivalents has decreased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Bristol-Myers
Company Analysis
BMY.SW valuation, rating, competitors, insights and company profile
Eyestock Rating
BMY.SW financial analysis by Eyestock methodology
Valuation
BMY.SW valuation using historical relative method
Statements
BMY.SW Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BMY.SW dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Bristol-Myers`s Cash and equivalents for the period ended 2024-06-30 are 6.7 B USD
